
Does vitamin C (incl. high-dose) treat myeloproliferative neoplasms?
Checked
Posts online say that vitamin C (incl. high-dose) helps with myeloproliferative neoplasms.
Some studies in people have looked at vitamin C (incl. high-dose) for myeloproliferative neoplasms. Below is what they found, and what is not known.
What studies show
As of , this is what studies of vitamin C (incl. high-dose) and myeloproliferative neoplasms found. We found 3 published papers on vitamin C (incl. high-dose) and myeloproliferative neoplasms. They were published between 1954 and 2023. 1 of them is a study in people. None of them compared people who got it with a group that did not. None was a study in animals, and none was only in cells in the lab.
What this means for you
Do not stop or change your treatment because of a story about vitamin C (incl. high-dose). A study in people is not proof that it helps you. If you are thinking about vitamin C (incl. high-dose), talk to your care team first.
This page explains what research has found so far. It is not medical advice. Talk to your doctor before you start, stop or change any treatment.
Sources
- A phase 2 trial of combination therapy with thalidomide, arsenic trioxide, dexamethasone, and ascorbic acid (TADA) in patients with overlap myelodysplastic/myeloproliferative neoplasms (MDS/MPN) or primary myelofibrosis (PMF). Cancer 2012. Study in people. PubMed
- Clinical and molecular characteristics associated with Vitamin C deficiency in myeloid malignancies; real world data from a prospective cohort. Leuk Res 2023. Other paper. PubMed
- Alcoholic cirrhosis; complicated by polycythemia vera and then myelogenous leukemia and tolerance of large doses of vitamin C. Med Times 1954. Other paper. PubMed


